Unresectable or Metastatic Hepatocellular Carcinoma
2 clinical trials · Condition
◉ Watch Unresectable or Metastatic Hepatocellular Carcinoma
| Record | Firm | Date |
|---|---|---|
| Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure (NCT07219459) | CatalYm GmbH | 2026-03-19 |
| Temsirolimus as Second-line Therapy in HCC (NCT01567930) | University of Tennessee Cancer Institute | 2010-02-01 |
Track Unresectable or Metastatic Hepatocellular Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.